drugset / Trial / NCT00984997

Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors

NCT00984997 ↗

Phase 2 Completed 38 enrolled M.D. Anderson Cancer Center
NaSingle-groupOpen-labelTreatment

Summary

1. To determine the outcome of patients with potentially resectable superior sulcus tumors of non-small cell histology treated by surgery followed by accelerated radiation therapy and chemotherapy. 2. To evaluate toxicity, the initial local-regional control rate, sites of and time to local and distant failures.

Timeline

Start
1993-10
Primary completion
2007-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 50 mg/m2 Intravenous
Subject Etoposide Small molecule — Oral

Indications